EXAS
Exact Sciences Corporation
Exact Sciences Corporation (EXAS) is a healthcare company focused on cancer screening diagnostics, with its most significant political signal being a $15.6M federal contract history and a direct holding by former President Donald J. Trump.
Govt Dependence
15/100
Regulatory Density
85/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL
BusinessWhat EXAS does
Exact Sciences Corporation develops and commercializes cancer screening tests, primarily the Cologuard colorectal cancer screening test. Revenue is generated from test sales to healthcare providers, with significant payments to physicians for services related to its tests, totaling $3.5M in 2024 per get_political_influence.doctor_payments. The company has federal contracts with the Department of Defense and Department of Veterans Affairs.
12 months past · 3 months futureEXAS activity timeline
Congress
buy
sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened
+ added
− trimmed
closed
holds
Bills
past action (this ticker)
upcoming markup (sector)
★ carveout (this ticker)
174 trading days ·
1 congressional trades shown
·
0 insider buys
·
7 13F filings
·
3 past bill actions
·
3 upcoming markups
Executive Branch ConflictsEXAS held by Trump-administration officials
1 cabinet/senior official reported EXAS positions in OGE Form 278 disclosures across 2 filings.
Lifetime Government AwardsEXAS federal contracts by year
$19M
total awarded · 2017–2026
140
contracts on file
2021
peak year ($5M)
Top contracts by award amount
$2.9M
Department of Veterans Affairs
2021-09-30
ONCOTYPE DX BREAST AND ONCOTYPE DX PROSTATE
$984K
Department of Veterans Affairs
2025-08-20
VHA BREAST CANCER MOLECULAR TESTING ORDER 2
$900K
Department of Veterans Affairs
2020-08-09
SARS-V2 COVID-19 TEST KITS
$899K
Department of Veterans Affairs
2020-04-21
COVID 19 TEST KITS
$701K
Department of Veterans Affairs
2025-08-18
ONCOTYPE DX TESTING
10 years · 140 contracts
Smart Money · 13F HoldingsHedge funds holding EXAS
$101.5M
Total EXAS held by tracked 13F funds
3
Funds with EXAS positions
D.E. Shaw & Co.
$51M
-98%
2025-12-31
Citadel Advisors
$28M
-93%
2025-12-31
D.E. Shaw & Co.
$22M
+104475%
2025-12-31
Politicians Trading EXASMembers of Congress with recent EXAS positions
1 politicians traded EXAS across 1 disclosed transactions totaling $8K (last 730 days).
Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just EXAS). 0-30 LOW · 30-60 MID · 60+ HIGH.
Congressional TradesWho in Congress is trading EXAS
2026-03-24
Kevin Hern
Sale
$1,001 - $15,000
2024-05-10
Josh Gottheimer
Sale
$1,001 - $15,000
2024-05-10
Josh Gottheimer
sale
$1,001 - $15,000
2024-02-01
Josh Gottheimer
Sale
$1,001 - $15,000
2024-02-01
Josh Gottheimer
sale
$1,001 - $15,000
2024-01-02
Kevin Hern
Sale
$1,001 - $15,000
2024-01-02
Kevin Hern
sale
$1,001 - $15,000
2023-11-13
Josh Gottheimer
sale
$1,001 - $15,000
2023-11-13
Josh Gottheimer
Sale
$1,001 - $15,000
2023-10-16
Josh Gottheimer
purchase
$1,001 - $15,000
2023-10-16
Josh Gottheimer
Purchase
$1,001 - $15,000
2023-09-15
Josh Gottheimer
Sale
$1,001 - $15,000
30+ trades on file · most recent 2026-04-03
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting EXASLive legislation impacting this stock
S.827 · 119th
Supporting Rural Veterans Access to Healthcare Services Act
HR.2001 · 119th
Action for Dental Health Act
HR.1860 · 119th
Women Veterans Cancer Care Coordination Act
HR.2068 · 119th
Veterans Patient Advocacy Act
HR.2020 · 119th
New Mexico Rural Veteran Health Care Access Act
S.999 · 119th
Public Health Improvement Act
HR.2045 · 119th
Medicare Dental, Vision, and Hearing Benefit Act of 2025
HR.2062 · 119th
To amend the Internal Revenue Code of 1986 to treat membership in a health care sharing ministry as a medical expense, and for oth
HR.2048 · 119th
Metastatic Breast Cancer Access to Care Act
HR.2085 · 119th
Mental Health Research Accelerator Act of 2025
Political ProfileWhere EXAS sits in Washington
[object Object]
STRUCTURAL: High regulatory density from healthcare sector bills (8 bills with impact_ratios 0.0002-0.0003) and $15.6M federal contract footprint per get_government_precedent. EVIDENTIARY: Direct stock holding by Donald J. Trump per get_executive_branch_exposure.by_ticker (2 positions, value up to $15,000) and one congressional sale (H001082) per Top congressional traders. Net: Limited lobbying (score 0) and no insider buys per get_corporate_insider_signal, balancing the Trump holding.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Regulatory scrutiny over physician payments under Sunshine ActCMS"get_political_influence.doctor_payments shows $3.5M in 2024 across 107,491 payments, indicating high volume subject to disclosure and potential review."
Regulatory opportunities
-
Expansion of federal contract base with DoD and VADepartment of Defense, Department of Veterans Affairs"get_government_precedent.federal_contracts_summary shows 133 contracts totaling $15.6M, providing recurring revenue stream."
Member intelligence layer
Live signals + predictions for EXAS — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades EXAS
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout EXAS & political exposure
Does Exact Sciences Corporation (EXAS) hold federal contracts?
Yes. Exact Sciences Corporation has 140 federal contract awards totaling $18,710,875, primarily from agencies including Department of Defense, Department of Veterans Affairs. See full contract list and amounts on this page.
Which Trump cabinet officials own EXAS stock?
1 Trump cabinet members or senior White House staff have disclosed holdings in EXAS on their OGE 278 financial disclosures, including Donald J. Trump. See the Cabinet Conflicts panel for details.
Has Congress traded EXAS stock?
61 congressional trades by 6 unique members of Congress, most recently on 2026-03-24. See the Congressional Trading panel for politician-by-politician breakdown.
What is EXAS political risk profile?
Government dependence: 15/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 0%.
How does GovGreed track EXAS political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. EXAS data is updated daily from these official federal sources.